Haas Jason

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$161,239.79
Insider Sells Quantity
1
Insider Sells Sum
$28,979.97

Insider Activity of Haas Jason

According to the SEC Form 4 filings, Haas Jason, being in a position of

  1. Chief Financial Officer at Syros Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 100000 shares for $161,240, and sold 137803 shares for $28,980,
    over all time since 2024-09-10, has bought 100000 shares for $161,240, and sold 137803 shares for $28,980.

The largest purchase of all time was on 2024-09-12 and amounted to 45344 shares of Syros Pharmaceuticals, Inc. for $76,006.

The largest sale of all time was on 2024-11-18 and amounted to 137803 shares of Syros Pharmaceuticals, Inc. for $28,980.

Biography of Haas Jason

No biography is available at this moment.

2024-11-18SaleSyros Pharmaceuticals, Inc.
SYRS
Chief Financial Officer
137,803
0.5433%
$0.21$28,9800%
2024-09-12PurchaseSyros Pharmaceuticals, Inc.
SYRS
Chief Financial Officer
45,344
0.1811%
$1.68$76,006+26.11%
2024-09-11PurchaseSyros Pharmaceuticals, Inc.
SYRS
Chief Financial Officer
19,293
0.073%
$1.58$30,446-0.51%
2024-09-10PurchaseSyros Pharmaceuticals, Inc.
SYRS
Chief Financial Officer
35,363
0.1314%
$1.55$54,788+26.6%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.